These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19563406)

  • 1. Hepatocellular apoptosis associated with cytotoxic T/natural killer-cell infiltration in chronic active EBV infection.
    Nomura Y; Kimura H; Karube K; Yoshida S; Sugita Y; Niino D; Shimizu K; Kimura Y; Aoki R; Kiyasu J; Takeuchi M; Hashikawa K; Hirose S; Ohshima K
    Pathol Int; 2009 Jul; 59(7):438-42. PubMed ID: 19563406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
    Suzuki K; Ohshima K; Karube K; Suzumiya J; Ohga S; Ishihara S; Tamura K; Kikuchi M
    Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.
    Iwatsuki K; Satoh M; Yamamoto T; Oono T; Morizane S; Ohtsuka M; Xu ZG; Suzuki D; Tsuji K
    Arch Dermatol; 2006 May; 142(5):587-95. PubMed ID: 16702496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus is present in neoplastic cytotoxic T cells in extranodal, and predominantly in B cells in nodal T non-Hodgkin lymphomas.
    Brink AA; ten Berge RL; van den Brule AJ; Willemze R; Chott A; Meijer CJ
    J Pathol; 2000 Aug; 191(4):400-6. PubMed ID: 10918215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD.
    Ohshima K; Kimura H; Yoshino T; Kim CW; Ko YH; Lee SS; Peh SC; Chan JK;
    Pathol Int; 2008 Apr; 58(4):209-17. PubMed ID: 18324913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dominant expression of interleukin-10 and transforming growth factor-beta genes in activated T-cells of chronic active Epstein-Barr virus infection.
    Ohga S; Nomura A; Takada H; Tanaka T; Furuno K; Takahata Y; Kinukawa N; Fukushima N; Imai S; Hara T
    J Med Virol; 2004 Nov; 74(3):449-58. PubMed ID: 15368517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus (EBV) latent membrane protein-1-specific cytotoxic T lymphocytes targeting EBV-carrying natural killer cell malignancies.
    Demachi-Okamura A; Ito Y; Akatsuka Y; Tsujimura K; Morishima Y; Takahashi T; Kuzushima K
    Eur J Immunol; 2006 Mar; 36(3):593-602. PubMed ID: 16479544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal T-cell and natural killer-cell lymphomas in Taiwan with special emphasis on 2 distinct cellular types: natural killer-like cytotoxic T cell and true natural killer cell.
    Tung CL; Hsieh PP; Chang JH; Chen RS; Chen YJ; Wang JS
    Hum Pathol; 2008 Jul; 39(7):1018-25. PubMed ID: 18482744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immune response to primary EBV infection: a role for natural killer cells.
    Williams H; McAulay K; Macsween KF; Gallacher NJ; Higgins CD; Harrison N; Swerdlow AJ; Crawford DH
    Br J Haematol; 2005 Apr; 129(2):266-74. PubMed ID: 15813855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection.
    Kimura H; Hoshino Y; Hara S; Sugaya N; Kawada J; Shibata Y; Kojima S; Nagasaka T; Kuzushima K; Morishima T
    J Infect Dis; 2005 Feb; 191(4):531-9. PubMed ID: 15655776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NK-cell repertoire is feasible for diagnosing Epstein-Barr virus-infected NK-cell lymphoproliferative disease and evaluating the treatment effect.
    Sawada A; Sato E; Koyama M; Higuchi B; Kusuki S; Kim JY; Takeshita Y; Sakata A; Sakata N; Okamura T; Yasui M; Inoue M; Kawa K
    Am J Hematol; 2006 Aug; 81(8):576-81. PubMed ID: 16823820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
    Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
    Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular lesion in a patient of chronic active Epstein-Barr virus infection with hypersensitivity to mosquito bites: vasculitis induced by mosquito bite with the infiltration of nonneoplastic Epstein-Barr virus-positive cells and subsequent development of natural killer/T-cell lymphoma with angiodestruction.
    Kanno H; Onodera H; Endo M; Maeda F; Chida S; Akasaka T; Sawai T
    Hum Pathol; 2005 Feb; 36(2):212-8. PubMed ID: 15754300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexpression of CD40 and CD40 ligand in Epstein-Barr virus-infected T and NK cells and their role in cell survival.
    Imadome K; Shimizu N; Arai A; Miura O; Watanabe K; Nakamura H; Nonoyama S; Yamamoto K; Fujiwara S
    J Infect Dis; 2005 Oct; 192(8):1340-8. PubMed ID: 16170750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revisiting the liver in human yellow fever: virus-induced apoptosis in hepatocytes associated with TGF-beta, TNF-alpha and NK cells activity.
    Quaresma JA; Barros VL; Pagliari C; Fernandes ER; Guedes F; Takakura CF; Andrade HF; Vasconcelos PF; Duarte MI
    Virology; 2006 Feb; 345(1):22-30. PubMed ID: 16278000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD95 (Fas) ligand expression of Epstein-Barr virus (EBV)-infected lymphocytes: a possible mechanism of immune evasion in chronic active EBV infection.
    Ohshima K; Suzumiya J; Sugihara M; Nagafuchi S; Ohga S; Kikuchi M
    Pathol Int; 1999 Jan; 49(1):9-13. PubMed ID: 10227719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nodal T/NK-cell lymphoma of nasal type: a clinicopathological study of six cases.
    Takahashi E; Asano N; Li C; Tanaka T; Shimada K; Shimada S; Yoshino T; Kojima M; Hara K; Eimoto T; Nakamura S
    Histopathology; 2008 Apr; 52(5):585-96. PubMed ID: 18370955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nodal CD8 positive cytotoxic T-cell lymphoma: a distinct clinicopathological entity.
    Mukai HY; Hasegawa Y; Kojima H; Okoshi Y; Takei N; Yamashita Y; Nagasawa T; Mori N
    Mod Pathol; 2002 Nov; 15(11):1131-9. PubMed ID: 12429791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus-associated T-/natural killer cell lymphoproliferative diseases.
    Yachie A; Kanegane H; Kasahara Y
    Semin Hematol; 2003 Apr; 40(2):124-32. PubMed ID: 12704589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency?
    Kimura H
    Rev Med Virol; 2006; 16(4):251-61. PubMed ID: 16791843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.